SCHEMBL12777155

SCHEMBL12777155

CC(C)(C)c1ccc2oc(-c3cc(-c4ccccc4-c4ccccc4)c4ccc5ccc(-c6ccccc6-c6ccccc6)c6ccc3c4c56)nc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.41
▸ RAB9A P51151 7/20 0.41
▸ GFER P55789 1/20 0.41
▸ SMN1; SMN2 Q16637 7/20 0.39
▸ KDM4E B2RXH2 5/20 0.39
▸ CASP3 P42574 3/20 0.39
▸ SENP7 Q9BQF6 3/20 0.39
▸ SENP6 Q9GZR1 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ SENP8 Q96LD8 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ MAPT P10636 5/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ USP2 O75604 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ TP53 P04637 3/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12777085 0.89 MAPT (0.47) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL12777067 0.87 NPC1 (0.48) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL12777153 0.86 KDM4E (0.56) NPC1RAB9ASMN1; SMN2KDM4ECASP3
SCHEMBL12777160 0.86 GAA (0.44) NPC1RAB9ASMN1; SMN2KDM4ECASP3
SCHEMBL12776887 0.85 ALDH1A1 (0.49) NPC1RAB9ASMN1; SMN2KDM4ECASP3
SCHEMBL12777088 0.84 MAPT (0.38) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL12776985 0.84 MAPT (0.53) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL12777070 0.83 ALDH1A1 (0.45) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL12777027 0.83 MAPT (0.52) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL12777214 0.82 NPC1 (0.53) NPC1RAB9AGFERSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7901794-B2 Material for light-emitting element and light emitting element TORAY INDUSTRIES, INC. (JP) 2011-03-08 — — US disclosed
US-7901794-B2 Material for light-emitting element and light emitting element TORAY INDUSTRIES, INC. (JP) 2011-03-08 — — US disclosed
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2009-03-12 — — US disclosed
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT PYM1, CRY1, S100A10 NPC1 2742/4885RAB9A 3169/4885GFER 3354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback